NEW YORK–(FILO D & # 39; BUSINESS) – Emblem,
the leader in blockchain for health, announced today that he has entered
in a partnership with Pharmagest Interactive, one of the leading pharmacies
software group in Europe, to allow patients to directly download their own
health data from pharmacies and health centers, placing patients at
treatment center. Patients will have individual access to join
Advanced clinical research using Blockchain technology to ensure the
control, integrity and traceability of health data.
The strategic partnership will accelerate the joint development of
Blockchain-based applications for patients and pharmacies and beyond
The commercial development of Embleema through the extended network of Pharmagest
of over 10,000 pharmacies in Europe. The partnership will also allow
Pharmagest to scale the adoption of its services among patients who are
already digitizing their prescription data through its current pharmacy
In July 2018, Embleema launched PatientTruth in the United States, the first
personal health record system based on blockchain, which allows patients
bring together their health history from disputed health records by allowing
full control over the sharing of health data. Patients receive counters
in exchange for their active participation in clinical research.
Emblem was the first company to offer practical means for patients
own digital resources for health, providing both control and monetization
without third-party data intermediaries.
Blockchain allows patients to own their data on a decentralized system
market, since all transactions are recorded on books distributed,
remove the need for a third party to authenticate movements. patients
have access to the complete audit trail of their health data and receive
automated payments via smart contracts.
The strategic partnership with Pharmagest will allow Embleema to
accelerate the development of its decentralized health data market,
a service for patients to connect with researchers to share and collect
relevant health data and accelerate drug development. Pharmagest will do it
be a leading partner in Europe, offering patients a network within its network
opportunity to opt for research.
Thierry Chapusot, CEO of Pharmagest, said: "We believe in the enormity
potential of blockchain technology in the healthcare sector that is
destined to become a key technology to protect data and guarantee
transparency for the patient. The system developed by Embleema is al
at the forefront in decentralizing and sharing data to better monitor the
efficacy and safety of drugs. With a world-class team, Embleema has
already demonstrated its potential with a solution that works and
generated interest from key partners in the pharmaceutical industry such as
it means reducing the time-to-market of innovative drugs. We are very
enthusiastic about the opportunity to participate in his deployment and anxious
create complementary synergies with our Group. "
Robert Chu, CEO of Embleema, added: "We are pleased with this strategy
partnership with the Pharmagest Group that will allow us to integrate ours
blockchain technology inside the different solutions already developed
from a group that has been at the forefront of innovation in Europe for
in the last 25 years. It will be the addition of Pharmagest to our shareholder base
give us the financial resources necessary for their rapid deployment
technologies for patients through pharmacies or medical institutions
equipped by Pharmagest. Through the deployment of this blockchain
large-scale technology for the benefit of patients, not just
in the United States, but now also in Europe. "
About Pharmagest Group
Pharmagest Group is the French leader of computer technology in pharmacies,
with a market share of over 42% and over 1,000 employees. The
The group's strategy is based on the core business of improving health care
through the innovation of information technology and developing two priorities
areas: 1 / Services and technologies for healthcare professionals, with a
focus on assisting pharmacies in the field of patient dressing
compliance; and 2 / technologies to improve the effectiveness of health care
systems. This strategy is performed through specialized business lines
developed by Pharmagest Group: IT solutions for pharmacy, e-Health
solutions, solutions for healthcare professionals, solutions for
pharmaceutical laboratories, devices and apps related to health and a
sales financing market.
These companies are divided into four divisions: Pharmacy – Europe
Solutions, solutions for health services and social assistance, e-Health
Solutions and FinTech.
is the patient-led health blockchain network for secure sharing
of personal medical records. Hosted on a private block of Ethereum,
The consolidated and highly secure repository of Embleema provides the
health ecosystem with an undisputed and holistic view of patients
medical history, Embleema is creating decentralized health data
economy by linking key stakeholders in the health sector,
directly with patients while maintaining patient data sovereignty.
CEO Robert Chu left his role as Senior Vice President, Global Technology
Solutions to IMS Health to establish Embleema in June 2017 and are supported
from a team of Harvard Medical health and technology executives
School, T-Systems, the Pharmaceuticals division of Pierre Fabre e
iBionext and Nokia / Withings Digital Health.
For more information, visit www.embleema.com
and follow Embleema on Twitter @Embleema,